• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Fanapt Falls Flat! Link from the Street.com





Same old story. Fanapt not on formulary in my area, and nobody wants to write it!!

Yep, but Novartis does not care. I just heard about a fellow district member now going on a PIP. I know for a fact that he/she has really tried, but this drug is such a dog in terms of coverage, indications, dosing, and everything else!